96 related articles for article (PubMed ID: 17132815)
1. SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice.
Khroyan TV; Zaveri NT; Polgar WE; Orduna J; Olsen C; Jiang F; Toll L
J Pharmacol Exp Ther; 2007 Feb; 320(2):934-43. PubMed ID: 17132815
[TBL] [Abstract][Full Text] [Related]
2. Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.
Zaveri NT; Jiang F; Olsen C; Polgar WE; Toll L
Bioorg Med Chem Lett; 2013 Jun; 23(11):3308-13. PubMed ID: 23623415
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics.
Ding H; Kiguchi N; Dobbins M; Romero-Sandoval EA; Kishioka S; Ko MC
Drugs; 2023 Jun; 83(9):771-793. PubMed ID: 37209211
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.
Sałat K; Furgała A; Sałat R
Inflammopharmacology; 2018 Apr; 26(2):361-374. PubMed ID: 29071457
[TBL] [Abstract][Full Text] [Related]
5. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.
Grenald SA; Young MA; Wang Y; Ossipov MH; Ibrahim MM; Largent-Milnes TM; Vanderah TW
Neuropharmacology; 2017 Apr; 116():59-70. PubMed ID: 28007501
[TBL] [Abstract][Full Text] [Related]
6. Targeting multiple opioid receptors - improved analgesics with reduced side effects?
Günther T; Dasgupta P; Mann A; Miess E; Kliewer A; Fritzwanker S; Steinborn R; Schulz S
Br J Pharmacol; 2018 Jul; 175(14):2857-2868. PubMed ID: 28378462
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide.
Hochrainer N; Serafin P; D'Ingiullo S; Mollica A; Granica S; Brytan M; Kleczkowska P; Spetea M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612817
[TBL] [Abstract][Full Text] [Related]
8. The role of mu opioid receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronide.
Nguyen AT; Marquez P; Hamid A; Lutfy K
Eur J Pharmacol; 2012 May; 682(1-3):86-91. PubMed ID: 22374262
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.
McLeod RL; Tulshian DB; Bolser DC; Varty GB; Baptista M; Fernandez X; Parra LE; Zimmer JC; Erickson CH; Ho GD; Jia Y; Ng FW; Korfmacher W; Xu X; Veals J; Smith-Torhan A; Wainhaus S; Fawzi AB; Austin TM; van Heek M; Hey JA
Eur J Pharmacol; 2010 Mar; 630(1-3):112-20. PubMed ID: 20006596
[TBL] [Abstract][Full Text] [Related]
10. Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA.
Islam A; Rahman MA; Brenner MB; Moore A; Kellmyer A; Buechler HM; DiGiorgio F; Verchio VR; McCracken L; Sumi M; Hartley R; Lizza JR; Moura-Letts G; Fischer BD; Keck TM
ACS Pharmacol Transl Sci; 2020 Oct; 3(5):907-920. PubMed ID: 33073190
[TBL] [Abstract][Full Text] [Related]
11. Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.
Goldberg LR; Kirkpatrick SL; Yazdani N; Luttik KP; Lacki OA; Babbs RK; Jenkins DF; Johnson WE; Bryant CD
Genes Brain Behav; 2017 Sep; 16(7):725-738. PubMed ID: 28594147
[TBL] [Abstract][Full Text] [Related]
12. IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics.
Rehrauer KJ; Cunningham CW
Pharmacol Res; 2023 Nov; 197():106966. PubMed ID: 37865129
[TBL] [Abstract][Full Text] [Related]
13. In vivo photopharmacology with light-activated opioid drugs.
McClain SP; Ma X; Johnson DA; Johnson CA; Layden AE; Yung JC; Lubejko ST; Livrizzi G; He XJ; Zhou J; Chang-Weinberg J; Ventriglia E; Rizzo A; Levinstein M; Gomez JL; Bonaventura J; Michaelides M; Banghart MR
Neuron; 2023 Dec; 111(24):3926-3940.e10. PubMed ID: 37848025
[TBL] [Abstract][Full Text] [Related]
14. The opioid receptor: emergence through millennia of pharmaceutical sciences.
Fairbanks CA; Peterson CD
Front Pain Res (Lausanne); 2023; 4():960389. PubMed ID: 38028425
[TBL] [Abstract][Full Text] [Related]
15. Modified synthesis of NOP receptor antagonist SB612111.
Perrey DA; Li JX; Zhang Y
Synthesis (Stuttg); 2017 Mar; 49(6):1394-1400. PubMed ID: 31571700
[TBL] [Abstract][Full Text] [Related]
16.
McClain SP; Ma X; Johnson DA; Johnson CA; Layden AE; Yung JC; Lubejko ST; Livrizzi G; Jenny He X; Zhou J; Ventriglia E; Rizzo A; Levinstein M; Gomez JL; Bonaventura J; Michaelides M; Banghart MR
bioRxiv; 2023 Feb; ():. PubMed ID: 36778286
[TBL] [Abstract][Full Text] [Related]
17. TH-030418: a potent long-acting opioid analgesic with low dependence liability.
Yu G; Yan LD; Li YL; Wen Q; Dong HJ; Gong ZH
Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):125-31. PubMed ID: 21594658
[TBL] [Abstract][Full Text] [Related]
18. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
19. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous targeting of multiple opioid receptor types.
Bird MF; Lambert DG
Curr Opin Support Palliat Care; 2015 Jun; 9(2):98-102. PubMed ID: 25872121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]